EU Guidelines for First-in-Human Studies
EU Guidelines for First-in-Human Studies Understanding EU Guidance on First-in-Human Clinical Trials First-in-human (FIH) studies represent the critical transition from preclinical to clinical development. They mark the first administration of an investigational medicinal product (IMP) to humans, usually healthy volunteers, but sometimes patients in the case of oncology or rare diseases. In the European Union…